COP Stock Overview
Provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
CompuGroup Medical SE & Co. KGaA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €22.06 |
52 Week High | €28.92 |
52 Week Low | €13.10 |
Beta | 0.82 |
1 Month Change | -0.36% |
3 Month Change | -3.25% |
1 Year Change | -21.94% |
3 Year Change | -56.49% |
5 Year Change | -70.19% |
Change since IPO | 173.42% |
Recent News & Updates
Recent updates
Acquisitions Of Pridok And AmbulApps Will Strengthen Product Portfolio And Operations In Northern Europe
The strategic focus on AI and cloud-based solutions aims to enhance efficiency and margins through innovative digital health advancements.Is It Too Late To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Nov 26CompuGroup Medical SE & Co. KGaA's (ETR:COP) Popularity With Investors Is Clear
Nov 08Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital
Sep 06Here's Why CompuGroup Medical SE KGaA (ETR:COP) Has A Meaningful Debt Burden
Aug 20What You Can Learn From CompuGroup Medical SE & Co. KGaA's (ETR:COP) P/E After Its 34% Share Price Crash
Aug 04CompuGroup Medical SE & Co. KGaA (ETR:COP) Just Reported Earnings, And Analysts Cut Their Target Price
Jul 18Is It Too Late To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Jul 15Investors Still Waiting For A Pull Back In CompuGroup Medical SE & Co. KGaA (ETR:COP)
Jun 11The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
May 24Earnings Release: Here's Why Analysts Cut Their CompuGroup Medical SE & Co. KGaA (ETR:COP) Price Target To €43.20
May 11CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Larger Dividend Than Last Year At €1.00
Apr 27CompuGroup Medical SE KGaA's (ETR:COP) Upcoming Dividend Will Be Larger Than Last Year's
Apr 12We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Mar 20CompuGroup Medical SE & Co. KGaA (ETR:COP) Shares Could Be 49% Below Their Intrinsic Value Estimate
Feb 08Investors Interested In CompuGroup Medical SE & Co. KGaA's (ETR:COP) Earnings
Jan 25Is It Time To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Jan 12The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
Dec 28We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Dec 15Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Potentially Undervalued?
Oct 09CompuGroup Medical SE KGaA (ETR:COP) Could Be Struggling To Allocate Capital
Sep 22Do CompuGroup Medical SE KGaA's (ETR:COP) Earnings Warrant Your Attention?
Sep 07Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 33% Discount?
Aug 23Here's Why CompuGroup Medical SE KGaA (ETR:COP) Can Manage Its Debt Responsibly
Jul 13At €46.82, Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Worth Looking At Closely?
Jun 24CompuGroup Medical SE KGaA (ETR:COP) Is Reinvesting At Lower Rates Of Return
May 27CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
May 11Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 32% Discount?
May 06We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Apr 06What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?
Mar 07Be Wary Of CompuGroup Medical SE KGaA (ETR:COP) And Its Returns On Capital
Feb 06An Intrinsic Calculation For CompuGroup Medical SE & Co. KGaA (ETR:COP) Suggests It's 28% Undervalued
Jan 21These 4 Measures Indicate That CompuGroup Medical SE KGaA (ETR:COP) Is Using Debt Reasonably Well
Jan 05Is Now An Opportune Moment To Examine CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Dec 06Shareholder Returns
COP | DE Healthcare Services | DE Market | |
---|---|---|---|
7D | -0.4% | 4.0% | 0.5% |
1Y | -21.9% | 10.3% | 14.4% |
Return vs Industry: COP underperformed the German Healthcare Services industry which returned 11.3% over the past year.
Return vs Market: COP underperformed the German Market which returned 14.6% over the past year.
Price Volatility
COP volatility | |
---|---|
COP Average Weekly Movement | 1.3% |
Healthcare Services Industry Average Movement | 6.0% |
Market Average Movement | 6.5% |
10% most volatile stocks in DE Market | 12.8% |
10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: COP has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: COP's weekly volatility has decreased from 8% to 1% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | 8,299 | Daniel Gotthardt | www.cgm.com |
CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells management software for registered physicians, medical care centers, and physician networks.
CompuGroup Medical SE & Co. KGaA Fundamentals Summary
COP fundamental statistics | |
---|---|
Market cap | €1.14b |
Earnings (TTM) | €27.00m |
Revenue (TTM) | €1.19b |
42.3x
P/E Ratio1.0x
P/S RatioIs COP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
COP income statement (TTM) | |
---|---|
Revenue | €1.19b |
Cost of Revenue | €787.98m |
Gross Profit | €400.57m |
Other Expenses | €373.58m |
Earnings | €27.00m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Jul 31, 2025
Earnings per share (EPS) | 0.52 |
Gross Margin | 33.70% |
Net Profit Margin | 2.27% |
Debt/Equity Ratio | 118.6% |
How did COP perform over the long term?
See historical performance and comparisonDividends
0.2%
Current Dividend Yield10%
Payout RatioDoes COP pay a reliable dividends?
See COP dividend history and benchmarksCompuGroup Medical SE KGaA dividend dates | |
---|---|
Ex Dividend Date | Aug 04 2025 |
Dividend Pay Date | Aug 06 2025 |
Days until Ex dividend | 77 days |
Days until Dividend pay date | 79 days |
Does COP pay a reliable dividends?
See COP dividend history and benchmarksCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/05/19 10:25 |
End of Day Share Price | 2025/05/16 00:00 |
Earnings | 2025/03/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CompuGroup Medical SE & Co. KGaA is covered by 14 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Knut Woller | Baader Helvea Equity Research |
Wolfgang Specht | Berenberg |
Gregory Ramirez | Bryan Garnier & Co |